Solid lipid nanoparticle-incorporated gel: the future treatment for skin infections?

Nanomedicine

Volumn 8, Issue 12, 2013, Pages 1901-1903

  Kumar, Abhinesh ^a   Sawant, Krutika K ^a  

^a M S UNIVERSITY OF BARODA   (India)

Author keywords

gel; skin targeting; solid lipid nanoparticle; topical application

Indexed keywords

CARBOMER; DRUG CARRIER; ETRETIN; NANOCARRIER; SOLID LIPID NANOPARTICLE; TERBINAFINE;

DERMATOMYCOSIS; DISPERSION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; DRUG RETENTION; DRUG STABILITY; DRUG TRANSPORT; GEL; HUMAN; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PSORIASIS; REVIEW; SKIN INFECTION; SKIN PENETRATION;

DRUG CARRIERS; GELS; HUMANS; LIPIDS; NANOPARTICLES; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; SKIN; SKIN ABSORPTION; SKIN DISEASES, INFECTIOUS;

EID: 84889601606     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.13.171     Document Type: Review

References (19)

1. Müller RH, Mehnert W, Lucks JS et al. Solid lipid nanoparticles (SLN)-An alternative colloidal carrier system for controlled drug delivery. Eur. J. Pharm. Biopharm. 41(1), 62-69 (1995
2. Müller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv. Drug Deliv. Rev. 54(Suppl. 1), S131-S155 (2002 (Pubitemid 35379959)
3. Pople PV, Singh KK Development and evaluation of topical formulation containing solid lipid nanoparticles of vitamin A. AAPS PharmSciTech 7(4), E63-E69 (2006
4. Shegokar R, Singh KK, Müller RH. Production and stability of stavudine solid lipid nanoparticles-from lab to industrial scale. Int. J. Pharm. 416(2), 461-470 (2011
5. Bhalekar MR, Pokharkar V, Madgulkar A, Patil N. Preparation and evaluation of miconazole nitrate-loaded solid lipid nanoparticles for topical delivery. AAPS PharmSciTech 10(1), 289-296 (2009
6. Montenegro L, Sinico C, Castangia I, Carbone C, Puglisi G. Idebenone-loaded solid lipid nanoparticles for drug delivery to the skin: In vitro evaluation. Int. J. Pharm. 434 (1-2), 169-174 (2012
7. Müller RH, Mäder K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery-A review of the state of the art. Eur. J. Pharm. Biopharm. 50(1), 161-177 (2000 (Pubitemid 30326695)
8. Wissing S, Müller R. Solid lipid nanoparticles (SLN)-A novel carrier for UV blockers. Pharmazie 56(10), 783-786 (2001 (Pubitemid 32971277)
9. de Vringer T, de Ronde HA. Preparation and structure of a water-in-oil cream containing lipid nanoparticles. J. Pharm. Sci. 84(4), 466-472 (1995
10. Mei Z, Chen H, Weng T, Yang Y, Yang X. Solid lipid nanoparticle and microemulsion for topical delivery of triptolide. Eur. J. Pharm. Biopharm. 56(2), 189-196 (2003 (Pubitemid 37072102)
11. Padois K, Cantieni C, Bertholle V, Bardel C, Pirot F, Falson F. Solid lipid nanoparticles suspension versus commercial solutions for dermal delivery of minoxidil. Int. J. Pharm. 416(1), 300-304 (2011
12. Wissing SA, Müller RH. The influence of solid lipid nanoparticles on skin hydration and viscoelasticity-in vivo study. Eur. J. Pharm. Biopharm. 56(1), 67-72 (2003 (Pubitemid 36802049)
13. Maia CS, Mehnert W, Schäfer-Korting M. Solid lipid nanoparticles as drug carriers for topical glucocorticoids. Int. J. Pharm. 196(2), 165-167 (2000 (Pubitemid 30105735)
14. Jenning V, Schäfer-Korting M, Gohla S. Vitamin A-loaded solid lipid nanoparticles for topical use: Drug release properties. J. Control Release 66(2-3), 115-126 (2000 (Pubitemid 30160850)
15. Vaghasiya H, Kumar A, Sawant K. Development of solid lipid nanoparticles based controlled release system for topical delivery of terbinafine hydrochloride. Eur. J. Pharm. Sci. 49(2), 311-322 (2013
16. Agrawal Y, Petkar K, Sawant K. Development, evaluation and clinical studies of Acitretin loaded nanostructured lipid carriers for topical treatment of psoriasis. Int. J. Pharm. 401(1-2), 93-102 (2010
17. Kovacevic A, Savic S, Vuleta G, Müller RH, Keck CM. Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): Effects on size, physical stability and particle matrix structure. Int. J. Pharm. 406(1-2), 163-172 (2011
18. Souza LG, Silva EJ, Martins AL et al. Development of topotecan loaded lipid nanoparticles for chemical stabilization and prolonged release. Eur. J. Pharm. Biopharm. 79(1), 189-196 (2011
19. Tiwari R, Pathak K. Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: Comparative analysis of characteristics, pharmacokinetics and tissue uptake. Int. J. Pharm. 415(1-2), 232-243 (2011